Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Gotlib

Showing results (21-30 of 246) with videos related to

Pageof 25
Sort By:
Blood|December 1, 2016
How I treat atypical chronic myeloid leukemiaJason Gotlib
Cancer Treatment and Research|February 21, 2008
Chronic eosinophilic leukemia/hypereosinophilic syndromeJason Gotlib
American Journal of Hematology|March 1, 2014
World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and managementJason Gotlib
American Journal of Hematology|July 16, 2011
World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and managementJason Gotlib
American Journal of Hematology|September 17, 2021
World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and managementWilliam Shomali, Jason Gotlib
Seminars in Hematology|March 28, 2012
Mast cells and eosinophils in mastocytosis, chronic eosinophilic leukemia, and non-clonal disordersJason Gotlib, Cem Akin
Blood|December 29, 2016
Myeloid neoplasms with eosinophiliaAndreas Reiter, Jason Gotlib
American Journal of Hematology|August 20, 2019
World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and managementWilliam Shomali, Jason Gotlib
Seminars in Cancer Biology|August 13, 2004
Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylateSteven Coutré, Jason Gotlib
American Journal of Hematology|March 29, 2024
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and managementWilliam Shomali, Jason Gotlib
Pageof 25

Showing results (21-30 of 246) with videos related to

Sort By:
Pageof 25
Blood|December 1, 2016
How I treat atypical chronic myeloid leukemiaJason Gotlib
Cancer Treatment and Research|February 21, 2008
Chronic eosinophilic leukemia/hypereosinophilic syndromeJason Gotlib
American Journal of Hematology|March 1, 2014
World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and managementJason Gotlib
American Journal of Hematology|July 16, 2011
World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and managementJason Gotlib
American Journal of Hematology|September 17, 2021
World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and managementWilliam Shomali, Jason Gotlib
Seminars in Hematology|March 28, 2012
Mast cells and eosinophils in mastocytosis, chronic eosinophilic leukemia, and non-clonal disordersJason Gotlib, Cem Akin
Blood|December 29, 2016
Myeloid neoplasms with eosinophiliaAndreas Reiter, Jason Gotlib
American Journal of Hematology|August 20, 2019
World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and managementWilliam Shomali, Jason Gotlib
Seminars in Cancer Biology|August 13, 2004
Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylateSteven Coutré, Jason Gotlib
American Journal of Hematology|March 29, 2024
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and managementWilliam Shomali, Jason Gotlib
Pageof 25